z-logo
open-access-imgOpen Access
Application of Animal Models in Cancer Research: Recent Progress and Future Prospects
Author(s) -
Zhitao Li,
Zheng Wen-ling,
Hanjin Wang,
Yufeng Cheng,
Yijiao Fang,
Fan Wu,
Guoqiang Sun,
Guan Sun,
Chengyu Lv,
Bingqing Hui
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s302565
Subject(s) - xenotransplantation , animal model , disease , cancer , tumor microenvironment , computer science , computational biology , risk analysis (engineering) , medicine , biology , transplantation , pathology , surgery , endocrinology
Animal models refers to the animal experimental objects and related materials that can simulate human body established in medical research. As the second-largest disease in terms of morbidity and mortality after cardiovascular disease, cancer has always been the focus of human attention all over the world, which makes it a research hotspot in the medical field. At the same time, more and more animal models have been constructed and used in cancer research. With the deepening of research, the construction methods of cancer animal models are becoming more and more diverse, including chemical induction, xenotransplantation, gene programming, and so on. In recent years, patient-derived xenotransplantation (PDX) model has become a research hotspot because it can retain the microenvironment of the primary tumor and the basic characteristics of cells. Animal models can be used not only to study the biochemical and physiological processes of the occurrence and development of cancer in objects but also for the screening of cancer drugs and the exploration of gene therapy. In this paper, several main tumor animal models and the application progress of animal models in tumor research are systematically reviewed. Finally, combined with the latest progress and development trend in this field, the future research of tumor animal model was prospected.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here